Chinese Anti-Cancer Association   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Tianjin China (1984)

Organization Overview

First Clinical Trial
2009
NCT00826891
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Chinese Anti-Cancer Association